Lanreotide | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Lanreotide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 8 USDMF, 4 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

FINISHED DOSAGE FORMULATIONS

100 FDF Dossiers, 9 FDA Orange Book, 52 Europe, 3 Canada, 24 Australia, 3 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;SUBCUTANEOUS - EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML), SOLUTION;SUBCUTANEOUS - EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML), SOLUTION;SUBCUTANEOUS - EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML), SOLUTION;SUBCUTANEOUS - EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML), SOLUTION;SUBCUTANEOUS - EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML), SOLUTION;SUBCUTANEOUS - EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 24 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

4 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Exclusivities, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

3 All

01 3IPSEN PHARMA

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

IPSEN PHARMA

LANREOTIDE ACETATE

PackExpo

Not Confirmed

02

IPSEN PHARMA

LANREOTIDE ACETATE

PackExpo

Not Confirmed

03

IPSEN PHARMA

LANREOTIDE ACETATE

PackExpo

Not Confirmed

Contact us
to update this info